# Manjusha Gaglani

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/manjusha-gaglani/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,348 |
| Field | Influenza Virus Research Studies |
| h-index | 67 |
| i10-index | 184 |
| Last Known Institution | Baylor College of Medicine |
| OpenAlex ID | https://openalex.org/A5081844185 |
| ORCID iD | https://orcid.org/0000-0002-3952-9230 |
| Works | 320 |

## Researcher papers

- [Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021](https://scholariq.org/papers/interim-estimates-of-vaccine-effectiveness-of-bnt162b2-and-mrna-1273-covid-19/)
- [Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study](https://scholariq.org/papers/clinical-severity-of-and-effectiveness-of-mrna-vaccines-against-covid-19-from/)
- [Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity](https://scholariq.org/papers/association-between-mrna-vaccination-and-covid-19-hospitalization-and-disease/)
- [Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines](https://scholariq.org/papers/prevention-and-attenuation-of-covid-19-with-the-bnt162b2-and-mrna-1273-vaccines/)
- [Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021](https://scholariq.org/papers/comparative-effectiveness-of-moderna-pfizer-biontech-and-janssen-johnson-and-amp/)
- [Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022](https://scholariq.org/papers/effectiveness-of-2-dose-bnt162b2-pfizer-biontech-mrna-vaccine-in-preventing-sars/)

## Researcher topics

- [Influenza Virus Research Studies](https://scholariq.org/topics/influenza-virus-research-studies/)
- [Respiratory viral infections research](https://scholariq.org/topics/respiratory-viral-infections-research/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Vaccine Coverage and Hesitancy](https://scholariq.org/topics/vaccine-coverage-and-hesitancy-2/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

## Researcher university

- [Baylor College of Medicine](https://scholariq.org/institutions/baylor-college-of-medicine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.